How to buy Cumberland Pharmaceuticals stock (CPIX)

Cumberland Pharmaceuticals is a drug manufacturers - specialty & generic business based in the US. Cumberland Pharmaceuticals shares (CPIX) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2.32 – a decrease of 2.52% over the previous week. Cumberland Pharmaceuticals employs 91 staff and has a trailing 12-month revenue of around $36.8 million.

Our top picks for where to buy Cumberland Pharmaceuticals stock

Buy Cumberland Pharmaceuticals stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Cumberland Pharmaceuticals stock price (NASDAQ: CPIX)

Use our graph to track the performance of CPIX stocks over time.

Cumberland Pharmaceuticals shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$2.32
52-week range	$1.04 - $3.05
50-day moving average more info button	$1.34
200-day moving average more info button	$1.47
Wall St. target price	$8.50
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.76

Is it a good time to buy Cumberland Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cumberland Pharmaceuticals price performance over time

Historical closes compared with the close of $2.34 from 2024-12-18

1 week (2024-12-12)	7.34%
1 month (2024-11-20)	114.68%
3 months (2024-09-19)	82.81%
6 months (2024-06-18)	50.97%

1 year (2023-12-19)	36.05%
2 years (2022-12-19)	8.33%
3 years (2021-12-17)	4.29
5 years (2019-12-19)	5.3

Cumberland Pharmaceuticals financials

Revenue TTM	$36.8 million
Gross profit TTM	$32.9 million
Return on assets TTM	-5.64%
Return on equity TTM	-36.07%
Profit margin	-29.55%
Book value	$1.77
Market Capitalization more info button	$32.9 million

TTM: trailing 12 months

Cumberland Pharmaceuticals share dividends

We're not expecting Cumberland Pharmaceuticals to pay a dividend over the next 12 months.

Have Cumberland Pharmaceuticals's shares ever split?

Cumberland Pharmaceuticals's shares were split on a 2:1 basis on 5 July 2007 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Cumberland Pharmaceuticals shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Cumberland Pharmaceuticals shares which in turn could have impacted Cumberland Pharmaceuticals's share price.

Cumberland Pharmaceuticals share price volatility

Over the last 12 months, Cumberland Pharmaceuticals's shares have ranged in value from as little as $1.04 up to $3.05. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cumberland Pharmaceuticals's is 0.219. This would suggest that Cumberland Pharmaceuticals's shares are less volatile than average (for this exchange).

Cumberland Pharmaceuticals overview

Cumberland Pharmaceuticals Inc. , a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; Sancuso, an injection for the treatment of chemotherapy treatment; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.

Frequently asked questions

null
What percentage of Cumberland Pharmaceuticals is owned by insiders or institutions?
Currently 44.802% of Cumberland Pharmaceuticals shares are held by insiders and 14.688% by institutions. How many people work for Cumberland Pharmaceuticals?
Latest data suggests 91 work at Cumberland Pharmaceuticals. When does the fiscal year end for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals's fiscal year ends in December. Where is Cumberland Pharmaceuticals based?
Cumberland Pharmaceuticals's address is: 1600 West End Avenue, Nashville, TN, United States, 37203 What is Cumberland Pharmaceuticals's ISIN number?
Cumberland Pharmaceuticals's international securities identification number is: US2307701092 What is Cumberland Pharmaceuticals's CUSIP number?
Cumberland Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 230770109